Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Common drug review"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Search alternatives
:
common drug »
common due
Showing
161
-
180
of
790
Search:
'"Common drug review"'
,
query time: 0.09s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
161
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary ty...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
162
CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
163
Patient group input submissions: Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2)
Published 2017
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
164
CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
165
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
166
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
167
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
168
Patient group input submissions: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
169
Clinical review report: Propiverine hydrochloride (Mictoryl/Mictoryl pediatric)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
170
Clinical review report: Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
171
CADTH Canadian Drug Expert Committee recommendation: Travoprost 0.003% (Izba -- Novartis Pharmaceuticals Canada inc. on behalf of Alcon Canada Inc.) : indication : for the reductio...
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
172
Clinical review report: AbobotulinumtoxinA (Dysport therapeutic) : (Ipsen Biopharmaceuticals Canada, Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
173
Clinical review report: Edoxaban (Lixiana)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
174
Pharmacoeconomic review report: Edoxaban (Lixiana)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
175
Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
176
Pharmacoeconomic review report: Tenofovir alafenamide (Vemlidy) (Gilead Sciences Canada, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug
review
...
”
Read Now
177
Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
178
Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
179
Pharmacoeconomic review report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue pharma)
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
Read Now
180
Pharmacoeconomic review report: Nitisinone (Orfadin) (Sobi Canada Inc.)
Published 2018
CADTH
“
...CADTH
common
drug
review
...
”
4
5
6
7
8
9
10
11
12
13
14
Back
Narrow Search
Year of Publication
From:
To:
Classification
610 - Medicine & health
581
330 - Economics
256
140 - Specific philosophical schools
83
700 - The arts; fine & decorative arts
76
580 - Plants (Botany)
11
380 - Commerce, communications & transportation
7
more ...
615 - Pharmacology & therapeutics
4
see all ...
less ...
Language
English
790
Collection
National Center for Biotechnology Information
790
Author
Canadian Agency for Drugs and Technologies in Health
729
CADTH Canadian Drug Expert Committee
210
Canadian Diabetes Association
4
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Recently Uploaded
Last Month
66
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=9&lookfor=%22Common+drug+review%22&type=Series
Send by Email
×
Loading...